| Literature DB >> 24250645 |
Mehrdad Roghani, Mohammad Reza Jalali-Nadoushan, Tourandokht Baluchnejadmojarad, Mohammad-Reza Vaez Mahdavi, Gholamali Naderi, Farshad Roghani Dehkordi, Mohammad Taghi Joghataei.
Abstract
Cardiovascular disorders continue to constitute major causes of morbidity and mortality in diabetic patients. In this study, the effect of chronic administration of sesame (Sesamum indicum L) seed feeding was studied on aortic reactivity of streptozotocin (STZ)-diabetic rats. Male diabetic rats received sesame seed-mixed food at weight ratios of 3% and 6% for 7 weeks, one week after diabetes induction. Contractile responses to KCl and phenylephrine (PE) and relaxation response to acetylcholine (ACh) and sodium nitroprusside (SNP) were obtained from aortic rings. Maximum contractile response of endothelium-intact rings to PE was significantly lower in sesame-treated diabetic rats (at a ratio of 6%) relative to untreated diabetics and endothelium removal abolished this difference. Endothelium-dependent relaxation to ACh was also significantly higher in sesame-treated diabetic rats (at a ratio of 6%) as compared to diabetic rats and pretreatment of rings with nitric oxide synthase inhibitor, N(G)-nitro-l-arginine methyl ester (L-NAME) significantly attenuated the observed response. Two-month diabetes also resulted in an elevation of malondialdehyde (MDA) and decreased superoxide dismutase (SOD) activity and sesame treatment significantly reversed the increased MDA content and restored activity of SOD. We thus conclude that chronic treatment of diabetic rats with sesame seed could in a dose-manner prevent some abnormal changes in vascular reactivity through nitric oxide and via attenuation of oxidative stress in aortic tissue and endothelium integrity is necessary for this beneficial effect.Entities:
Keywords: Aorta; Diabetes mellitus; Sesame seed; Sesamum indicum L; Streptozotocin
Year: 2013 PMID: 24250645 PMCID: PMC3813278
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1Body weight and serum glucose concentration at different weeks (mean ± SEM). * p < 0.05, ** p < 0.005, *** p < 0.001, **** p < 0.0005, ***** p < 0.00001 (as compared to week 0 in the same group) # p < 0.05 (Versus diabetic in the same week).
Figure 2Cumulative concentration-response curves for KCl in aortic preparations 8 weeks after experiment in the presence (A) and absence (B) of endothelium (mean ± SEM).
Figure 3Cumulative concentration-response curves for PE in aortic preparations 8 weeks after experiment in the presence (A) and absence (B) of endothelium (mean ± SEM). * p < 0.05 (as compared to diabetic).
Figure 4Cumulative concentration-response curves for ACh in endothelium-intact aortic rings precontracted with PE 8 weeks after experiment. Relaxation responses are expressed as a percentage of the submaximal contraction induced by phenylephrine which produced 70-80% of maximal response (mean ± SEM). * p < 0.05 (as compared to diabetic).
Figure 5Cumulative concentration-response curves for ACh in endothelium-intact aortic rings precontracted with phenylephrine in the presence and absence of L-NAME 8 weeks after the experiment in control and diabetic rats. Relaxation responses are expressed as a percentage of the submaximal contraction induced by phenylephrine which produced 70-80% of maximal response (mean ± SEM). * p < 0.05 (as compared to diabetic).
Figure 6Maximum relaxation response to acetylcholine (ACh) in aortic rings precontracted with phenylephrine in the presence and absence of indomethacin (INDO) eight weeks after experiment in control and diabetic rats. Relaxation responses are expressed as a percentage (mean ± SEM). * p < 0.05 (as compared to diabetic).
Malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in aortic tissue of studied groups
|
|
|
|
|---|---|---|
| Control (n=7) | 5.7 ± 0.5 | 117 ± 6 |
| Control + Sesame6% (n=5) | 5.3 ± 0.6 | 123 ± 8 |
| Diabetic (n=6) | 9.2 ± 0.7** | 76 ± 8* |
| Diabetic + Sesame6% (n=7) | 6.7 ± 0.6# | 108 ± 7# |
* p < 0.005, ** p < 0.001 (vs. control group); # p < 0.05 (vs. diabetic group)